Annual Shareholders Equity
$4.95 B
+$348.39 M+7.57%
31 December 2023
Summary:
BioMarin Pharmaceutical annual stockholders equity is currently $4.95 billion, with the most recent change of +$348.39 million (+7.57%) on 31 December 2023. During the last 3 years, it has risen by +$845.55 million (+20.59%). BMRN annual shareholders equity is now at all-time high.BMRN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$5.41 B
+$127.10 M+2.40%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly stockholders equity is currently $5.41 billion, with the most recent change of +$127.10 million (+2.40%) on 30 September 2024. Over the past year, it has increased by +$516.50 million (+10.55%). BMRN quarterly shareholders equity is now at all-time high.BMRN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.6% | +10.6% |
| 3 y3 years | +20.6% | +26.9% |
| 5 y5 years | +66.8% | +76.1% |
BMRN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +20.6% | at high | +26.9% |
| 5 y | 5 years | at high | +66.8% | at high | +76.1% |
| alltime | all time | at high | +6492.2% | at high | +5001.6% |
BioMarin Pharmaceutical Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.41 B(+2.4%) |
| June 2024 | - | $5.29 B(+4.2%) |
| Mar 2024 | - | $5.07 B(+2.5%) |
| Dec 2023 | $4.95 B(+7.6%) | $4.95 B(+1.1%) |
| Sept 2023 | - | $4.90 B(+2.4%) |
| June 2023 | - | $4.78 B(+2.7%) |
| Mar 2023 | - | $4.66 B(+1.2%) |
| Dec 2022 | $4.60 B(+7.9%) | $4.60 B(+0.8%) |
| Sept 2022 | - | $4.57 B(+1.4%) |
| June 2022 | - | $4.50 B(+2.6%) |
| Mar 2022 | - | $4.39 B(+2.9%) |
| Dec 2021 | $4.27 B(+3.9%) | $4.27 B(-0.0%) |
| Sept 2021 | - | $4.27 B(+0.6%) |
| June 2021 | - | $4.24 B(+1.9%) |
| Mar 2021 | - | $4.16 B(+1.4%) |
| Dec 2020 | $4.11 B(+31.5%) | $4.11 B(+1.3%) |
| Sept 2020 | - | $4.05 B(+25.2%) |
| June 2020 | - | $3.24 B(-0.1%) |
| Mar 2020 | - | $3.24 B(+3.8%) |
| Dec 2019 | $3.12 B(+5.2%) | $3.12 B(+1.6%) |
| Sept 2019 | - | $3.07 B(+3.8%) |
| June 2019 | - | $2.96 B(+0.8%) |
| Mar 2019 | - | $2.94 B(-1.1%) |
| Dec 2018 | $2.97 B(+5.7%) | $2.97 B(+1.8%) |
| Sept 2018 | - | $2.91 B(+1.0%) |
| June 2018 | - | $2.89 B(+2.8%) |
| Mar 2018 | - | $2.81 B(-0.1%) |
| Dec 2017 | $2.81 B(+1.5%) | $2.81 B(-0.2%) |
| Sept 2017 | - | $2.81 B(+0.6%) |
| June 2017 | - | $2.80 B(+1.0%) |
| Mar 2017 | - | $2.77 B(+0.1%) |
| Dec 2016 | $2.77 B(+15.2%) | $2.77 B(+4.6%) |
| Sept 2016 | - | $2.65 B(+38.0%) |
| June 2016 | - | $1.92 B(-16.3%) |
| Mar 2016 | - | $2.29 B(-4.6%) |
| Dec 2015 | $2.40 B(+57.1%) | $2.40 B(+4.7%) |
| Sept 2015 | - | $2.29 B(-2.7%) |
| June 2015 | - | $2.36 B(-2.8%) |
| Mar 2015 | - | $2.43 B(+58.7%) |
| Dec 2014 | $1.53 B(+13.9%) | $1.53 B(+1.3%) |
| Sept 2014 | - | $1.51 B(+3.2%) |
| June 2014 | - | $1.46 B(+0.1%) |
| Mar 2014 | - | $1.46 B(+8.9%) |
| Dec 2013 | $1.34 B(+32.0%) | $1.34 B(+5.1%) |
| Sept 2013 | - | $1.28 B(+1.4%) |
| June 2013 | - | $1.26 B(+0.6%) |
| Mar 2013 | - | $1.25 B(+23.1%) |
| Dec 2012 | $1.02 B(+31.4%) | $1.02 B(+0.1%) |
| Sept 2012 | - | $1.02 B(+1.5%) |
| June 2012 | - | $1.00 B(+29.6%) |
| Mar 2012 | - | $771.95 M(-0.1%) |
| Dec 2011 | $773.05 M | $773.05 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $774.54 M(+5.8%) |
| June 2011 | - | $732.30 M(+1.6%) |
| Mar 2011 | - | $720.84 M(+0.5%) |
| Dec 2010 | $717.26 M(+122.6%) | $717.26 M(+22.5%) |
| Sept 2010 | - | $585.66 M(+61.4%) |
| June 2010 | - | $362.96 M(+5.1%) |
| Mar 2010 | - | $345.24 M(+7.2%) |
| Dec 2009 | $322.19 M(+16.4%) | $322.19 M(+6.0%) |
| Sept 2009 | - | $303.85 M(+7.2%) |
| June 2009 | - | $283.43 M(+3.5%) |
| Mar 2009 | - | $273.94 M(-1.0%) |
| Dec 2008 | $276.68 M(+47.4%) | $276.68 M(+16.3%) |
| Sept 2008 | - | $237.90 M(+5.3%) |
| June 2008 | - | $226.03 M(+8.1%) |
| Mar 2008 | - | $209.17 M(+11.4%) |
| Dec 2007 | $187.73 M(+59.4%) | $187.73 M(+7.6%) |
| Sept 2007 | - | $174.54 M(+4.1%) |
| June 2007 | - | $167.60 M(+1.8%) |
| Mar 2007 | - | $164.71 M(+39.8%) |
| Dec 2006 | $117.80 M(-252.1%) | $117.80 M(-3.5%) |
| Sept 2006 | - | $122.12 M(+149.8%) |
| June 2006 | - | $48.89 M(+6.3%) |
| Mar 2006 | - | $46.01 M(-159.4%) |
| Dec 2005 | -$77.46 M(+14.0%) | -$77.46 M(+18.5%) |
| Sept 2005 | - | -$65.38 M(-40.8%) |
| June 2005 | - | -$110.44 M(+22.4%) |
| Mar 2005 | - | -$90.23 M(+32.7%) |
| Dec 2004 | -$67.98 M(-157.7%) | -$67.98 M(-580.0%) |
| Sept 2004 | - | $14.16 M(-67.2%) |
| June 2004 | - | $43.19 M(-56.3%) |
| Mar 2004 | - | $98.77 M(-16.2%) |
| Dec 2003 | $117.85 M(+19.6%) | $117.85 M(-17.0%) |
| Sept 2003 | - | $141.96 M(-12.6%) |
| June 2003 | - | $162.44 M(-2.1%) |
| Mar 2003 | - | $165.90 M(+68.4%) |
| Dec 2002 | $98.54 M(-38.2%) | $98.54 M(-15.2%) |
| Sept 2002 | - | $116.21 M(-11.1%) |
| June 2002 | - | $130.78 M(-9.4%) |
| Mar 2002 | - | $144.37 M(-9.5%) |
| Dec 2001 | $159.55 M(+127.9%) | $159.55 M(+89.6%) |
| Sept 2001 | - | $84.17 M(-9.5%) |
| June 2001 | - | $93.00 M(+50.6%) |
| Mar 2001 | - | $61.76 M(-11.8%) |
| Dec 2000 | $69.99 M(-28.9%) | $69.99 M(-12.1%) |
| Sept 2000 | - | $79.65 M(-4.3%) |
| June 2000 | - | $83.20 M(-7.3%) |
| Mar 2000 | - | $89.73 M(-8.8%) |
| Dec 1999 | $98.38 M(+234.6%) | $98.38 M(-7.9%) |
| Sept 1999 | - | $106.80 M(+513.8%) |
| June 1999 | - | $17.40 M(-30.7%) |
| Mar 1999 | - | $25.10 M |
| Dec 1998 | $29.40 M | - |
FAQ
- What is BioMarin Pharmaceutical annual stockholders equity?
- What is the all time high annual shareholders equity for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual shareholders equity year-on-year change?
- What is BioMarin Pharmaceutical quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly shareholders equity year-on-year change?
What is BioMarin Pharmaceutical annual stockholders equity?
The current annual shareholders equity of BMRN is $4.95 B
What is the all time high annual shareholders equity for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual stockholders equity is $4.95 B
What is BioMarin Pharmaceutical annual shareholders equity year-on-year change?
Over the past year, BMRN annual stockholders equity has changed by +$348.39 M (+7.57%)
What is BioMarin Pharmaceutical quarterly stockholders equity?
The current quarterly shareholders equity of BMRN is $5.41 B
What is the all time high quarterly shareholders equity for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly stockholders equity is $5.41 B
What is BioMarin Pharmaceutical quarterly shareholders equity year-on-year change?
Over the past year, BMRN quarterly stockholders equity has changed by +$516.50 M (+10.55%)